Alesta Therapeutics

Alesta Therapeutics company information, Employees & Contact Information

Updated June 2026

Quick answer

Alesta Therapeutics is a Biotechnology Research company and founded in 2021. It has approximately 13 employees on record. Contact data was last refreshed in June 2026. Find Alesta Therapeutics's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Alesta Therapeutics email format Alesta Therapeutics management contacts

Related company profiles:

Alesta Therapeutics is a pioneering company based in Leiden, Netherlands, dedicated to the development of first-in-class small molecules that target GCN2. Our commitment to advanced, high-quality chemistry has led us to develop a clinical candidate with an extensive pre-GLP toxicology and CMC package.

Company Details

Employees
13
Founded
2021
Address
J.h. Oortweg 21, Leiden,south Holland 2333 Ch,netherlands
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
https://alestatherapeutics.com/
HQ
Leiden, South Holland
Competitors
Hybridize Therapeutics, Leyden Labs, Coave Therapeutics, Aspect Biosystems, Droia Ventures, Verdiva Bio, Light Horse Therapeutics, Candel Therapeutics, Solid Biosciences, Tenvie Therapeutics.
Looking for a particular Alesta Therapeutics employee's phone or email?

Alesta Therapeutics Questions

News

Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases - PR Newswire

Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases PR Newswire

1cBio and Alesta Therapeutics Announce Exclusive Global Licensing Agreement for a Novel Potentially First-in-Class Small Molecule for Hypophosphatasia - PR Newswire

1cBio and Alesta Therapeutics Announce Exclusive Global Licensing Agreement for a Novel Potentially First-in-Class Small Molecule for Hypophosphatasia PR Newswire

Alesta Therapeutics: €65 Million (Series A) Raised To Develop Small Molecule Therapies For Rare Diseases - Pulse 2.0

Alesta Therapeutics: €65 Million (Series A) Raised To Develop Small Molecule Therapies For Rare Diseases Pulse 2.0

Alesta Therapeutics Raises €65M in Series A Funding - FinSMEs

Alesta Therapeutics Raises €65M in Series A Funding FinSMEs

Alesta Therapeutics describes new GCN2 inhibitors for cancer - BioWorld MedTech

Alesta Therapeutics describes new GCN2 inhibitors for cancer BioWorld MedTech

Companies like Alesta Therapeutics

Candel Therapeutics logo - Similar company to Alesta Therapeutics

Candel Therapeutics

69
Verdiva Bio logo - Similar company to Alesta Therapeutics

Verdiva Bio

53
Leyden Labs logo - Similar company to Alesta Therapeutics

Leyden Labs

89
Droia Ventures logo - Similar company to Alesta Therapeutics

Droia Ventures

20
Solid Biosciences logo - Similar company to Alesta Therapeutics

Solid Biosciences

135
Coave Therapeutics logo - Similar company to Alesta Therapeutics

Coave Therapeutics

45
Tenvie Therapeutics logo - Similar company to Alesta Therapeutics

Tenvie Therapeutics

32
Hybridize Therapeutics logo - Similar company to Alesta Therapeutics

Hybridize Therapeutics

4
Aspect Biosystems logo - Similar company to Alesta Therapeutics

Aspect Biosystems

119
Light Horse Therapeutics logo - Similar company to Alesta Therapeutics

Light Horse Therapeu...

35

Top Alesta Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant